Caren Heller1, Joyce E Balls-Berry2, Jill Dumbauld Nery3, Patricia J Erwin4, Dawn Littleton4, Mimi Kim5, Winston P Kuo6. 1. Weill Cornell Medical College, Department of Medicine, Division of Medical Ethics, United States. 2. Mayo Clinic, Department of Health Sciences Research, Division of Epidemiology, United States; Mayo Clinic, Center for Clinical and Translational Science Office for Community Engagement in Research, United States. Electronic address: ballsberry.joyce@mayo.edu. 3. University of California San Diego, Clinical and Translational Research Institute, United States. 4. Mayo Clinic Libraries, United States. 5. NC TraCS Institute, The University of North Carolina at Chapel Hill, United States; Center for Biobehavioral Health Disparities, United States. 6. Interferon Expression Signature Diagnostics, Cambridge, MA 02139, United States; Harvard Catalyst, Laboratory for Innovative Translational Technologies, Harvard Medical School, Boston, MA 02115, United States.
Abstract
BACKGROUND: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. OBJECTIVE: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. DESIGN: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. RESULTS: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. CONCLUSION: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.
BACKGROUND: Underrepresentation of racial and ethnic minorities in clinical trials remains a reality while they have disproportionately higher rates of health disparities. OBJECTIVE: The purpose of this study was to identify successful community-engaged interventions that included health care providers as a key strategy in addressing barriers to clinical trial enrollment of underrepresented patients. DESIGN: A systematic review of the literature on interventions addressing enrollment barriers to clinical trials for racial and ethnic minorities was performed in Ovid MEDLINE, EBSCO Megafile, and EBSCO CINAHL. The systematic review identified 360 studies, and 20 were selected using the inclusion criteria. An iterative process extracted information from the eligible studies. RESULTS: The 20 selected studies were analyzed and then grouped by first author, nature of the clinical research initiative, priority populations, key strategies, and study outcomes. Nine of the studies addressed cancer clinical trials and 11 related to chronic medical conditions, including diabetes, hypertension management, and chronic kidney disease. The key strategies employed were categorized according to their presumed impact on barriers incurred at distinct steps in study recruitment: clinical trial awareness, opportunity to participate, and acceptance of enrollment. The strategies were further categorized by whether they would address barriers associated with minority perceptions of the research process and barriers related to how studies were designed and implemented. CONCLUSION: Multiple and flexible strategies targeting providers and participants at provider sites and within communities might be needed to enroll underrepresented populations into clinical trials.
Authors: Margo Michaels; Elisa S Weiss; John A Guidry; Natasha Blakeney; Liz Swords; Brian Gibbs; Samantha Yeun; Bruce Rytkonen; Robert Goodman; S Lisbeth Jarama; Amanda L Greene; Shilpa Patel Journal: J Cancer Educ Date: 2012-03 Impact factor: 2.037
Authors: Camellus O Ezeugwu; Aurelia Laird; C Daniel Mullins; Daljeet S Saluja; Reed A Winston Journal: J Natl Med Assoc Date: 2011 Sep-Oct Impact factor: 1.798
Authors: Marya Viorst Gwadz; Pablo Colon; Amanda S Ritchie; Noelle R Leonard; Charles M Cleland; Marion Riedel; DeShannon Bowens; Angela D Banfield; Patricia Chang; Robert Quiles; Donna Mildvan Journal: Curr HIV/AIDS Rep Date: 2010-11 Impact factor: 5.071
Authors: Constance M Wiemann; Mariam R Chacko; Jacinda C Tucker; Mary M Velasquez; Peggy B Smith; Ralph J DiClemente; Kirk von Sternberg Journal: J Pediatr Adolesc Gynecol Date: 2005-12 Impact factor: 1.814
Authors: Sherrie F Wallington; Chiranjeev Dash; Vanessa B Sheppard; Tawara D Goode; Bridget A Oppong; Everett E Dodson; Rhonda N Hamilton; Lucile L Adams-Campbell Journal: Am J Prev Med Date: 2015-10-21 Impact factor: 5.043
Authors: Robert M Cronin; Rebecca N Jerome; Brandy Mapes; Regina Andrade; Rebecca Johnston; Jennifer Ayala; David Schlundt; Kemberlee Bonnet; Sunil Kripalani; Kathryn Goggins; Kenneth A Wallston; Mick P Couper; Michael R Elliott; Paul Harris; Mark Begale; Fatima Munoz; Maria Lopez-Class; David Cella; David Condon; Mona AuYoung; Kathleen M Mazor; Steve Mikita; Michael Manganiello; Nicholas Borselli; Stephanie Fowler; Joni L Rutter; Joshua C Denny; Elizabeth W Karlson; Brian K Ahmedani; Christopher J O'Donnell Journal: Epidemiology Date: 2019-07 Impact factor: 4.822
Authors: Grace C Hillyer; Melissa Beauchemin; Dawn L Hershman; Moshe Kelsen; Frances L Brogan; Rossy Sandoval; Karen M Schmitt; Andria Reyes; Mary Beth Terry; Andrew B Lassman; Gary K Schwartz Journal: Clin Trials Date: 2020-02-03 Impact factor: 2.486
Authors: Adebowale Odulana; Mimi M Kim; Melissa Green; Yhenneko Taylor; Daniel L Howard; Paul Godley; Giselle Corbie-Smith Journal: J Relig Health Date: 2014-04
Authors: Zachary R Simoni; Michelle Martin; Jennifer A Wenzel; Elise D Cook; Badrinath Konety; Selwyn M Vickers; Moon S Chen; Mona N Foaud; Raegan W Durant Journal: J Racial Ethn Health Disparities Date: 2016-11-08